Epstein–Barr Virus Replication in Interferon-treated Cells

References

1. Adams A., Strander H., Cantell K. 1975; Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon. Journal of General Virology 28:207–217
   [Google Scholar]
2. Arrand J. R., Rymo L., Walsh J. E., Bjorck E., Lindahl T., Griffin B. E. 1981; Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments. Nucleic Acids Research 9:2999–3014
   [Google Scholar]
3. Baer R., Bankier A.T., Biggin M.D., Deininger P.L., Farrell P.J., Gibson T.J., Hatfull G., Hudson G.S., satchwell S. C., Séguin C., Tuffnell P. S., Barrell B. G. 1984; DNA sequence and expression of the B95-8 Epstein-Bar virus genome. Nature London: 310207–211
   [Google Scholar]
4. Bauer G. 1983; Quantitative analysis of the cooperative effect between inducers of Epstein–Bar virus antigen synthesis. Journal of General Virology 64:1337–1346
   [Google Scholar]
5. Biggin M., Bodescot M., Perricaudet M., Farrell P. J. 1987; Epstein–Barr virus gene expression in P3HR1-superinfected Raji cells. Journal of Virology 61:3120–3132
   [Google Scholar]
6. Cho M.-S., Milman G., Hayward S. D. 1985; A second Epstein–Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein. Journal of Virology 56:860–866
   [Google Scholar]
7. Clemens M. J., Mcnurlan M. A. 1985; Regulation of cell proliferation and differentiation by interferons. Biochemical Journal 226:345–360
   [Google Scholar]
8. Crawford D. H., Ando I. 1986; EB virus induction is associated with B-cell maturation. Immunology 59:405–409
   [Google Scholar]
9. Davison A. J., Scott J. E. 1986; DNA sequence of the major capsid protein of herpes simplex virus type 1. Journal of General Virology 67:2279–2286
   [Google Scholar]
10. Doetsch P.W., Suhadolnik R.J., Sawada Y., Mosca J.D., Flick M.B., Reichenbach N.L., Dang A.Q., Wu J.M., Charubala R., Pfleiderer W., Henderson E. E. 1981; Core (2′-5′)oligoadenylate and the cordycepin analog: inhibitors of Epstein‒Barr virus-induced transformation in the absence of interferon. Proceedings of the National Academy of SciencesU.S.A. 78:6699–6703
    [Google Scholar]
11. Exley R., Gordon J., Nathan P., Walker L., Clemens M. J. 1987; Anti-proliferative effects of interferons on Daudi Burkitt lymphoma cells: induction of cell differentiation and loss of response to autocrine growth factors. International Journal of Cancer 40:53–57
    [Google Scholar]
12. Farrell P. J. 1987; Epstein–Barr virus (B95-8 strain). In Genetic Maps99–107 O’Brien S. J. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
13. Feinberg A. P., Vogelstein B. 1984; A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Analytical Biochemistry 137:266–267
    [Google Scholar]
14. Gergely L., Klein G., Ernberg I. 1971; Host cell macromolecular synthesis in cells containing EBV-induced early antigens, studied by combined immunofluorescence and radioautography. Virology 45:22–29
    [Google Scholar]
15. Gewert D. R., Shah S., Clemens M. J. 1981; Inhibition of cell division by interferons: changes in the transport and intracellular metabolism of thymidine in human lymphoblastoid (Daudi) cells. European Journal of Biochemistry 116:487–492
    [Google Scholar]
16. Gibson T., Stockwell P., Ginsburg M., Barrell B. G. 1984; Homology between two EBV early genes and HSV ribonucleotide reductase and 38K genes. Nucleic Acids Research 12:5087–5098
    [Google Scholar]
17. Ho Y.-S., subhendu C., Hsu S.-M. 1987; Induction of differentiation of African Burkitt’s lymphoma cells by phorbol ester: possible relation with early B cells. Cancer Investigation 5:101–107
    [Google Scholar]
18. Hoffman G. J., Lazarowitz S. G., Hayward S. D. 1980; Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Proceedings of the National Academy of SciencesU.S.A. 77:2979–2983
    [Google Scholar]
19. Hummel M., Kieff E. 1982; Epstein–Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells. Journal of Virology 43:262–272
    [Google Scholar]
20. Johnson D. A., Gautsch J. W., Sportsman J. R., Elder J. H. 1984; Improved technique utilizing non-fat dried milk for analysis of proteins and nucleic acids transferred to nitrocellulose. Gene Analytical Techniques 1:3–8
    [Google Scholar]
21. Lvovsky E., Levine P.H., Fucillo D., Ablashi D.V., Bengall Z.H., Armstrong G.R., Levy H.B. 1981; Epstein–Barr virus and Herpesvirus saimiri: sensitivity to interferons and interferon inducers. Journal of the National Cancer Institute 66:1013–1019
    [Google Scholar]
22. Maniatis T., Fritsch E. F., Sambrook J. 1982; Molecular Cloning. A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
23. Menezes J., Patel P., Dussault H., Ioncas J., Leibold W. 1976; Effect of interferon on lymphocyte transformation and nuclear antigen production by Epstein–Barr virus. Nature London: 260:430–432
    [Google Scholar]
24. Minty A.J., Caravatti M., Robert B., Cohen A., Daubas P., Weydert A., Gros F., Buckingham M.E. 1981; Mouse α-actin mRNAs. Construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse a-actin mRNA. Journal of Biological Chemistry 256:1008–1014
    [Google Scholar]
25. Pearson G. R., Vroman B., Chase B., sculley t., Hummel M., Kieff E. 1983; Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. Journal of Virology 47:193–201
    [Google Scholar]
26. Pestka S., Langer J. A., Zoon K. C., samuel C. E. 1987; Interferons and their actions. Annual Review of Biochemistry 56:727–777
    [Google Scholar]
27. Sample J., Lancz G., Nonoyama M. 1986; Mapping of genes in BamHI fragment M of Epstein‒Barr DNA that may determine the fate of viral infection. Journal of Virology 57:145–154
    [Google Scholar]
28. Schaffer F.M., Benedict S.H., Petsche D., Lau A., Williams B.R.G., Mills G.B., Gelfand E.W. 1988; Interferon and phorbol esters down-regulate slgM expression by independent pathways. Journal of Cellular Physiology 134:245–252
    [Google Scholar]
29. Takimoto T., Ishikawa S., Umeda R., Ogura H., Hatano M. 1985; Effects of human interferon on cell proliferation and antigens induced by Epstein–Barr virus in nasopharyngeal carcinoma. Otolaryngology-Head and Neck Surgery 93:500–504
    [Google Scholar]
30. Tovey M. G., Dron M., Gresser I. 1982; Interferon enhances the expression of Epstein–Barr early antigen in Daudi cells. Journal of General Virology 60:31–38
    [Google Scholar]
31. Vroman B., Luka J., Rodriguez M., Pearson G. R. 1985; Characterization of a major protein with a molecular weight of 160,000 associated with the viral capsid of Epstein–Barr virus. Journal of Virology 53:107–113
    [Google Scholar]
32. Zeng Y., Zhong J. M., De the G., Wu S. H., Hou Y. t., Miao X. Q. 1982; Enhancement of spontaneous VCA and EA induction in B95 8 cells and EA induction in Raji cells treated with human leukocyte interferon. Intervirology 18:33–37
    [Google Scholar]